Standard antiemetic therapy recommended by each of the guidelines [National Comprehensive Cancer Network(NCCN), European Society for Medical Oncology, American Society of Clinical Oncology(ASCO), Japa
Sponsors
Hokkaido Lung Cancer Clinical Study Group
Conditions
Lung Cancer
Phase 2
Randomized phase II study of rikkunshito on chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy for lung cancer (HOT1403)
RecruitingJPRN-UMIN000014240
Start: 2014-06-16Target: 62Updated: 2026-06-29
Randomized phase II study of rikkunshito on chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy for lung cancer (HOT1402)
Active, not recruitingJPRN-UMIN000014239
Start: 2014-06-13Target: 58Updated: 2026-06-29